Rankings
▼
Calendar
BBLG Q4 2019 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena
BBLG
Bone Biologics Corporation
$2M
Q4 2019 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$277,629
Net Income
-$531,147
EPS (Diluted)
$76.48
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$297,689
Free Cash Flow
-$297,689
Stock-Based Comp.
$3,126
Balance Sheet
Total Assets
$30,827
Total Liabilities
$12M
Stockholders' Equity
-$12M
Cash & Equivalents
$24,145
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$277,629
-$1M
+77.6%
Net Income
-$531,147
-$1M
+63.9%
← FY 2019
All Quarters
Q1 2020 →